Incyte (NASDAQ:INCY) and Enable Injections, Inc. (“Enable”) today announced a new partnership to develop and commercialize specific assets in Incyte’s portfolio, including its investigational, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback